Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white population

Long-term treatment of multiple sclerosis with glatiramer acetate: Natural history of the subtypes of anti-glatiramer acetate antibodies and their correlation with clinical efficacy

(2010) Dimitros Karussis et al.   JOURNAL OF NEUROIMMUNOLOGY

B-CELL ACTIVATING FACTOR OF THE TNF FAMILY IS UPREGULATED IN NEUROMYELITIS OPTICA

(2010) K. Okada et al.   NEUROLOGY

Effector Functions of Antiaquaporin-4 Autoantibodies in Neuromyelitis Optica

(2009) Romain Cayrol et al.   Annals of the New York Academy of Sciences

Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica

(2009) JH Min et al.   Multiple Sclerosis Journal

Neuromyelitis Optica and Non–Organ-Specific Autoimmunity

(2008) Sean J. Pittock et al.   ARCHIVES OF NEUROLOGY

Interferon-β increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity

(2008) M. Krumbholz et al.   BRAIN

Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome

(2008) Lahar R Mehta et al.   Multiple Sclerosis Journal